Clinical Trial: The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders
Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders
Brief Summary: To evaluate Efficacy and Safety of oral Atorvastatin and Dexamethasone on conservative treatment for Chronic Subdural Hematoma (CSDH) patients with Coagulation Disorders
Detailed Summary:
Study design: Two-arm,Evaluator-blinded study
Subjects: CSDH patients with Coagulation Disorders(Conservative treatment is adopted)
Sample size: 60 cases, 30 in Atorvastatin and Dexamethasone-treated group, 30 in Atorvastatin-treated group.
Sponsor: Oriental Neurosurgery Evidence-Based-Study Team
Current Primary Outcome: Changes of hematoma volume [ Time Frame: 2,5,12 weeks during treatment ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Outcome score (GOSE) in subjects [ Time Frame: 2,5,12 weeks during treatment ]
- Changes of peripheral blood for later tested SDF-1a, Treg, CXCR4 and related analysis [ Time Frame: 2,5,12 weeks during treatment ]
- Changes of neurological symptoms and signs [ Time Frame: 2,5,12 weeks during treatment ]
- Recurrence and prognosis of patient failure in those conservative treatment [ Time Frame: 2,5,12 weeks during treatment ]
- Outcome score (ADL-BI Scale) in subjects [ Time Frame: 2,5,12 weeks during treatment ]
Original Secondary Outcome: Same as current
Information By: Oriental Neurosurgery Evidence-Based-Study Team
Dates:
Date Received: July 11, 2014
Date Started: July 2014
Date Completion: September 2015
Last Updated: March 25, 2015
Last Verified: March 2015